Erich Mohr, PhD, RPsych
Chairman and Chief Executive Officer at MedGenesis Therapeutix, Inc.
Location: Vancouver, Canada
Erich Mohr, PhD, RPsych, is the chairman and CEO of MedGenesis Therapeutix Inc., which he founded in 2005. Dr. Mohr, a professor of medicine and psychology at the University of Ottawa until 1997, has over 27 years of experience in experimental therapeutics of CNS disorders. He is credited with over 150 publications, books, book chapters and abstracts and has edited the Handbook of Clinical Trials: The neurobehavioral approach. Dr. Mohr has chaired and/or served on several regulatory advisory panels for the approval of new products for the treatment of neurodegenerative disease and is the former chairman and CEO of CroMedica Global, Inc. (merged with PRA International in 2002) and the co-founder of several biotechnology companies. Over the course of his career, Dr. Mohr has overseen and/or participated in dozens of clinical development programs resulting in a number of approved drugs.